COMP <GO>
HSCS vs CLGN // ENTERPRISE SCALE & MARKET CAP
HeartSciences Inc. (NASDAQ) VS. CollPlant Biotechnologies Ltd (NASDAQ) • 15-METRIC TALLY: HSCS 1
— CLGN 4
▲ ENTERPRISE SCALE & MARKET CAP LEADER: HSCS
LAST: $3.61 (+7.12%) • MKT CAP: $17.5M
market-cap
$17.5M
LAST: $4.40 (+11.39%) • MKT CAP: $12.7M
market-cap
$12.7M
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (HSCS VS. CLGN)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | HSCS | CLGN | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 59.10% | 64.80% | -5.70 | CLGN | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | -35.00% | -35.00% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | -60.00% | -60.00% | 0.00 | TIE | /operating-margins <GO> |
| Net Profit Margin | -60.00% | -60.00% | 0.00 | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | -0.70% | 180.00% | -180.70 | CLGN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 5/9 | -3.00 | CLGN | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 47.7 | 56.3 | -8.62 | CLGN | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap ACTIVE | $17.5M | $12.7M | $4.8M | HSCS | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | HSCS REV | CLGN REV | HSCS GROSS % | CLGN GROSS % | HSCS FCF | CLGN FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $4.3K | $2.4M | 59.1% | 64.8% | -$7.4M | -$9.4M |
| FY 2024 | $4.3K | $515.0K | 56.8% | -50.0% | -$7.4M | -$14.6M |
| FY 2023 | $18.6K | $11.0M | — | — | -$6.1M | -$2.8M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
HSCS // BETA —
CLGN // BETA —